Tom joined Satsuma Pharmaceuticals in January 2019 as our Chief Financial Officer. Tom has more than 25 years of experience working in companies ranging from start-ups to large public companies, and has served in a variety of roles, including executive leadership, finance, investor relations, operations, strategy, business/corporate development, and commercialization. Prior to joining Satsuma, Tom served as Chief Financial Officer at Protagonist Therapeutics, Inc., a public biopharmaceutical company, from February 2016 to January 2019; as Chief Financial Officer for Arcadia Biosciences, Inc., a public biopharmaceutical company, from March 2015 to September 2015; as Chief Financial Officer of Sorbent Therapeutics, Inc., a biopharmaceutical company, from January 2014 to July 2014; as a consultant to Sorbent and a variety of health care and technology companies from September 2011 to December 2013; as Vice President of Finance & Administration of ChemGenex Pharmaceuticals Ltd., a biopharmaceutical company, from December 2009 until its acquisition by Cephalon in August 2011; and as Vice President of Finance & Administration of Nodality, Inc., a biotechnology company, from March 2007 to May 2009. Tom has also served in finance and operations roles in medical device, technology, and other services companies. Tom received B.A. degree from Pomona College, and an M.B.A. from The UCLA Anderson Graduate School of Management.